The Patent Finder

Vernalis (R&D) Ltd.

34 patents currently held · Updated Nov 15, 2026
24 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

1
Ending by 2030
Feb 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 18, 2026
  • 2 fees due Feb 18 to 25, 2027 · next Feb 18
  • 2 fees due Mar 1 to 17, 2027 · next Mar 1
  • 2 fees due Apr 29, 2027
  • 1 fee due Jun 5, 2027
    The maintenance fee for Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same (US 11,833,162) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 2 fees due Oct 14 to 26, 2027 · next Oct 14

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,163,747Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-Isopropyl-PHENYL)-4-(4-Morpholin-4-Ylmethyl-PHENYL)-ISOXAZOLE-3-Carboxylic Acid Ethylamide and Formulations Comprising These Forms
In force
 · High confidence
In forceHigh confidence
US 9,120,791Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,603,854Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,258,626Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,321,748Aminopyridine derived compounds as LRRK2 inhibitors
In force
 · High confidence
In forceHigh confidence
US 9,393,248Aminopyridine Derived Compounds as LRRK2 Inhibitors
In force
 · Medium confidence
In forceMedium confidence
US 9,108,983Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,598,427Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,265,323Pyrrole Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
In force
 · Low confidence
In forceLow confidence
US 10,688,101Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 34 patents shown.
Pro members see all 34.
Pro members: see all 34 patents
Also on record, not counted in the 34: 24 patents in force now held by others · 19 lapsed for an unpaid fee · 16 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 3 abandoned · 24 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited